v3.26.3
Convertible Preferred Stock and Stockholders' Deficit (Tables)
6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Company's stock option activity

A summary of the Company’s stock option activity under the 2020 Plan is as follows:

 

 

 

Options

 

Outstanding at December 31, 2025

 

 

1,178,288

 

Granted

 

 

386,564

 

Exercised

 

 

(219,189

)

Forfeited

 

 

(1,333

)

Expired

 

 

 

Outstanding at June 30, 2026

 

 

1,344,330

 

Exercisable at June 30, 2026

 

 

525,503

 

Vested and expected to vest at June 30, 2026

 

 

1,344,330

 

Schedule of Stock-based compensation expense recognized for all equity awards

Stock-based compensation expense recognized for all equity awards has been included in the statements of operations as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Research and development

 

 

388

 

 

 

233

 

 

 

629

 

 

 

443

 

General and administrative

 

 

189

 

 

 

21

 

 

 

271

 

 

 

42

 

Total stock-based compensation expense

 

$

577

 

 

$

254

 

 

$

900

 

 

$

485